On the other hand, the accumulation of therapeutic liposomal nanoparticles inside tumor microenvironment theoretically enhances the susceptibility to chemotherapy and/or radiotherapy of cancer cells, by hampering pro‐tumor activities of CD68‐positive TAMs [14, 15]. This evidence concerns the gene CD68 and neoplasm.